Approved consistent with revisions to the CDC Supporting Statement included in the public docket under supporting statements. Additionally, CDC acknowledges the limitations of utilizing Knowledge Networks - specifically that this methodology will not produce representative or generalizable results.
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
08/31/2008
12 Months From Approved
4,385
0
0
1,127
0
0
0
0
0
This project involves the evaluation of the HIV Testing Social
Marketing Campaign (HTSMC), a CDC-sponsored social marketing campaign aimed at increasing HIV testing rates among young, single, African American women. The CDC has designed an efficacy study to evaluate the HTSMC and its messages under controlled conditions. The study entails selecting a sample of single African American females, ages 18 to 34, with less than 4 years of college education and collecting baseline data on their knowledge, attitudes, beliefs, intentions, and behaviors related to HIV testing. The study represents an ``efficacy'' methodology in that participants will be divided into treatment and control conditions. Participants in the treatment condition will be exposed to campaign materials including radio advertisements, a billboard, and an informational booklet that will be distributed over the Internet. Thus the study participants' exposure will occur under controlled conditions, without the distractions and variability of potential exposure in the real world. As part of the advertisement stimuli package, the billboard advertisement will appear as part of the online log-in for each stimuli session in order to simulate the appearance of a sign. Therefore, we do not estimate any additional burden for exposure to the billboard advertisement.
Key outcomes related to the HTSMC will be measured in two follow-up surveys. The first follow-up survey will occur 2 weeks after the
baseline survey. The second follow-up survey will occur 6 weeks after the baseline survey. Comparisons of changes in these outcomes would then be made between participants in the treatment and control
conditions. Findings from this study will be used by CDC and its
partners to inform current and future program activities.
We expect a total of 1,630 participants to complete the baseline
survey. The 1,630 participants who complete the baseline survey will be randomly assigned to the treatment or control condition. 815
participants (the treatment condition) will be exposed to the radio ad and booklet. Of the 1,630 participants who completed the baseline
survey, we expect 1,140 to complete the first follow-up survey. Of the 1,140 who complete the first follow-up survey, we expect 800 to
complete the second follow-up survey, which will have fewer questions than the first follow-up survey because it will only pertain to questions about behavior change and selected behavioral intentions.
There are no costs to the respondents other than their time.
US Code:
42 USC 241
Name of Law: Part A. Research and Investigation General
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
HTSMC Six-week Follow-up Survey
Supporting Statement part B and Refs 8-9-2007 (2).doc
Attachment 3. 60-Day FRN 0920-06BL.pdf
HTSMC Six-week Follow-up Survey